Fieldpoint Private Securities, LLC Bio N Tech Se Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 45 shares of BNTX stock, worth $5,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 60
25.0%
Holding current value
$5,292
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$967 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$531 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$518 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$213 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...